. 2022 Aug 7;65(10-11):280–287. doi: 10.1002/jlcr.3994
© 2022 The Authors. Journal of Labelled Compounds and Radiopharmaceuticals published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
FIGURE 1.
Radioiodinated nuclear medicines and bioconjugation reagents